ResearcherGerman Cancer Research CenterActive in the last 2 years
Sebastian Zschaeck
Matched on ORCID iD 0000-0003-3109-0662; OpenAlex author ID A5007131086. Sources: ClinicalTrials.gov.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 2 (principal investigator on 2)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper, 1 trial · 2022: none · 2023: none · 2024: 1 paper, 1 trial
Papers 4
- 68Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradioth… Last author DOI 10.7150/thno.95329↗
- Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an in-silico study: Gastrointestinal organs remain critical. Co-author DOI 10.1016/j.ctro.2020.12.001↗
- Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer. Co-author DOI 10.1186/s13014-018-1165-0↗
- Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients. Co-author DOI 10.1371/journal.pone.0186341↗
Trials 2
- Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors Principal investigator NCT04889742↗
- Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells Principal investigator NCT04628806↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Esther G.C. Troost · 2 shared papers, 2018–2021 · strength 0.28
- Paper Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an in-silico study: Gas… DOI 10.1016/j.ctro.2020.12.001↗
- Paper Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrat… DOI 10.1186/s13014-018-1165-0↗
- Sarah Stefanowicz · 2 shared papers, 2018–2021 · strength 0.28
- Paper Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an in-silico study: Gas… DOI 10.1016/j.ctro.2020.12.001↗
- Paper Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrat… DOI 10.1186/s13014-018-1165-0↗
- Pirus Ghadjar · 2 shared papers, 2017–2024 · strength 0.24
- Paper 68Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer … DOI 10.7150/thno.95329↗
- Paper Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and… DOI 10.1371/journal.pone.0186341↗
- Uwe Pelzer · 2 shared papers, 2017–2024 · strength 0.24
- Paper 68Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer … DOI 10.7150/thno.95329↗
- Paper Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and… DOI 10.1371/journal.pone.0186341↗
- Christopher Neumann · 1 shared paper, 2024 · strength 0.18
- Giulia Metzger · 1 shared paper, 2024 · strength 0.18
- Marcus Bahra · 1 shared paper, 2017 · strength 0.06
- Marianne Sinn · 1 shared paper, 2017 · strength 0.06
- Fritz Klein · 1 shared paper, 2017 · strength 0.06
- Hanno B. Riess · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.